This review covers GEP peptide hormone excess syndromes, including somatostatinomas, PPomas, and neurotensinomas. Early diagnosis and understanding unique clinical features are crucial for managing these rare neuroendocrine tumors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: